Free Trial

COMPASS Pathways (CMPS) News Today

COMPASS Pathways logo
$3.26 -0.12 (-3.58%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$3.26 +0.00 (+0.03%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CMPS Latest News

Compass Pathways completes dosing in Part A of Phase 3 psilocybin trial
Morgan Stanley Remains a Buy on COMPASS Pathways (CMPS)
Get COMPASS Pathways News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter.

CMPS Media Mentions By Week

CMPS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMPS
News Sentiment

0.00

0.58

Average
Medical
News Sentiment

CMPS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMPS Articles
This Week

3

3

CMPS Articles
Average Week

Get COMPASS Pathways News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CMPS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners